Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Transplantation Proceedings|February 1, 1991
Hepatitis C in liver transplant recipientsA E Read, E Donegan, J Lake, et al.Journal of Medical Virology|October 23, 1998
Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant modelH M Hassoba, M G Pessoa, N A Terrault, et al.Journal of Hepatology|April 27, 2000
HCV-related fibrosis progression following liver transplantation: increase in recent yearsM Berenguer, L Ferrell, J Watson, et al.Pediatric Research|June 15, 1999
GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplantO Elkayam, H M Hassoba, L D Ferrell, et al.Viral Immunology|March 29, 2001
Direct functional analysis of epitope-specific CD8+ T cells in peripheral bloodX S He, B Rehermann, J Boisvert, et al.Transplantation|February 27, 1997
Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infectionM Reiser, N Terrault, D R Nelson, et al.Hepatology (Baltimore, Md.)|November 1, 1996
Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremiaS Zhou, N A Terrault, L Ferrell, et al.Epilepsia|June 15, 1999
Pharmacokinetics of fosphenytoin in patients with hepatic or renal diseaseF T Aweeka, M D Gottwald, J G Gambertoglio, et al.Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramersX S He, B Rehermann, F X López-Labrador, et al.The New England Journal of Medicine|October 21, 1999
Lamivudine as initial treatment for chronic hepatitis B in the United StatesJ L Dienstag, E R Schiff, T L Wright, et al.Pageof 11